Structure of Complex of Synthetic HIV-1 Protease with a Substrate-Based Inhibitor at 2.3 Å Resolution

Maria Miller(Frederick National Laboratory for Cancer Research), Jens Schneider(California Institute of Technology), Bangalore K. Sathyanarayana(Frederick National Laboratory for Cancer Research), Mihaly V. Toth(Washington University in St. Louis), Garland R. Marshall(Washington University in St. Louis), Leigh Clawson(California Institute of Technology), Linda Selk(California Institute of Technology), Stephen B. H. Kent(California Institute of Technology), Alexander Wlodawer(Frederick National Laboratory for Cancer Research)
Science
December 1, 1989
Cited by 687

Abstract

The structure of a complex between a peptide inhibitor with the sequence N-acetyl-Thr-Ile-Nle-psi[CH2-NH]-Nle-Gln-Arg.amide (Nle, norleucine) with chemically synthesized HIV-1 (human immunodeficiency virus 1) protease was determined at 2.3 A resolution (R factor of 0.176). Despite the symmetric nature of the unliganded enzyme, the asymmetric inhibitor lies in a single orientation and makes extensive interactions at the interface between the two subunits of the homodimeric protein. Compared with the unliganded enzyme, the protein molecule underwent substantial changes, particularly in an extended region corresponding to the "flaps" (residues 35 to 57 in each chain), where backbone movements as large as 7 A are observed.


Related Papers

No related papers found

Powered by citation graph analysis